Cellebrite DI (CLBT) Non Operating Investment Income (2021 - 2025)

Cellebrite DI (CLBT) has reported Non Operating Investment Income for 5 consecutive years, with $5.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Non Operating Investment Income rose 31.08% year-over-year to $5.5 million; the TTM figure through Dec 2025 stood at $24.2 million (up 108.11% YoY), while the FY2025 annual figure was $24.2 million, up 107.27% from the prior year.
• Non Operating Investment Income came in at $5.5 million for Q4 2025 at Cellebrite DI, up from $5.3 million in the prior quarter.
• The five-year high for Non Operating Investment Income was $7.1 million in Q1 2025, with the low at -$224.0 million in Q3 2024.
• Average Non Operating Investment Income over 5 years is -$16.9 million, with a median of -$47500.0 recorded in 2023.
• Across the five-year window, Non Operating Investment Income slumped 257550.57% in 2024 and soared 6474.0% in 2025, its largest moves.
• Year by year, Non Operating Investment Income stood at $120000.0 in 2021, then slumped by 63.33% to $44000.0 in 2022, then sank by 62245.45% to -$27.3 million in 2023, then jumped by 115.25% to $4.2 million in 2024, then soared by 31.08% to $5.5 million in 2025.
• According to Business Quant data, Non Operating Investment Income over the past three periods registered $5.5 million, $5.3 million, and $6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.